Skip to main content
. 2018 May 22;9:431. doi: 10.3389/fphar.2018.00431

Table 1.

Human cells and cell lines used for assessment of GPCR expression.

Type of cancer Cells or cell lines used Source of cells or cell lines
B-cell chronic lymphocytic leukemia (CLL) Patient-derived primary cells Normal human B cells UCSD Moores Cancer Ctr
Bone marrow stromal natural killer (NK) cells that support CLL cell growth NK cells immortalized with telomerase reverse transcriptase UCSD Moores Cancer Ctr
Colon cancer T-84, Caco-2 cell lines ATCC
Triple-negative breast cancer BT-20, HS-578, MDA-MB-157, MDA-MB-436 cell lines ATCC
Pancreatic ductal adenocarcinoma 34E/79E patient-derived cells (PDAC) cells and PDAC tumors Human control pancreatic ductal epithelial cells AsPC-1, MiaPaCa-2 cell lines UCSD Moores Cancer Ctr. ATCC
Pancreatic ductal adenocarcinoma 5 primary patient-derived CAFs Human PSCs: Corresponding “normal” precursor cells Lowy lab, UCSD Moores Cancer Ctr ScienCell Research Laboratories (#3830; ScienCell Research Laboratories, Carlsbad, CA, United States)